Danaher Corporation (DHR)
Mexican Exchange · Mexico · prices in MXN · close of 22 Oct 2026
Key indicators
| Last close | MXN 4,295.00 |
|---|---|
| 52-week range | 2,795.00 – 4,400.00 |
| Return, 1 month / 3 months | +15.1% / +38.5% |
| Return, 1 year / 3 years | +7.4% / +14.5% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 34.1% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 0.61M MXN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Danaher Corporation is a science and technology company based in Washington, D.C. It serves customers in life sciences, diagnostics and biotechnology through businesses that make laboratory instruments, diagnostic analysers, filtration and purification products, and imaging equipment. Its brands supply hospitals, research laboratories, pharmaceutical companies and industrial customers with tools used in medical testing, drug development and scientific research.
On this site Danaher Corporation appears as a stock on the Mexican Exchange (Mexico), code DHR, with prices in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Danaher Corporation (DHR) trades on the Mexican Exchange in Mexico. It last closed at MXN 4,295.00 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 128 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.4% and over the last three months it rose 38.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.6% | ||
| From 52-week high | 0.0% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 38.5% | ||
| 6-month return | 28.8% | ||
| 12-month return, skipping the last month | -6.7% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.61M MXN | ||
| Zero-volume days | 46.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.4% |
|---|---|
| 1 month | +15.1% |
| 3 months | +38.5% |
| 6 months | +28.8% |
| 1 year | +7.4% |
| 3 years | +14.5% |
| 5 years | −23.1% |
Signals
| 50-day / 200-day average | 3,724.64 / 3,504.22 |
|---|---|
| Golden / death cross (60 days) | Golden, 16 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 65.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Dec 2019 | MXN 0.1700 |
| 26 Sep 2019 | MXN 0.1700 |
| 27 Jun 2019 | MXN 0.1700 |
| 28 Mar 2019 | MXN 0.1700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.